Kaisa Health Group Holdings Limited

SEHK:876 Rapport sur les actions

Capitalisation boursière : HK$121.0m

Kaisa Health Group Holdings Croissance future

Future contrôle des critères 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Kaisa Health Group Holdings.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Medical Equipment croissance des bénéfices39.2%
Taux de croissance des recettesn/a
Rendement futur des capitaux propresn/a
Couverture par les analystes

None

Dernière mise à journ/a

Mises à jour récentes de la croissance future

Recent updates

Investors Aren't Buying Kaisa Health Group Holdings Limited's (HKG:876) Revenues

Sep 25
Investors Aren't Buying Kaisa Health Group Holdings Limited's (HKG:876) Revenues

Here's Why Shareholders Should Examine Kaisa Health Group Holdings Limited's (HKG:876) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Kaisa Health Group Holdings Limited's (HKG:876) CEO Compensation Package More Closely

Benign Growth For Kaisa Health Group Holdings Limited (HKG:876) Underpins Stock's 30% Plummet

Feb 07
Benign Growth For Kaisa Health Group Holdings Limited (HKG:876) Underpins Stock's 30% Plummet

Kaisa Health Group Holdings Limited's (HKG:876) Prospects Need A Boost To Lift Shares

Dec 21
Kaisa Health Group Holdings Limited's (HKG:876) Prospects Need A Boost To Lift Shares

The Market Doesn't Like What It Sees From Kaisa Health Group Holdings Limited's (HKG:876) Earnings Yet As Shares Tumble 42%

Jun 07
The Market Doesn't Like What It Sees From Kaisa Health Group Holdings Limited's (HKG:876) Earnings Yet As Shares Tumble 42%

We're A Little Worried About Kaisa Health Group Holdings' (HKG:876) Cash Burn Rate

Mar 14
We're A Little Worried About Kaisa Health Group Holdings' (HKG:876) Cash Burn Rate

Here's Why Kaisa Health Group Holdings (HKG:876) Must Use Its Cash Wisely

Oct 12
Here's Why Kaisa Health Group Holdings (HKG:876) Must Use Its Cash Wisely

Kaisa Health Group Holdings' (HKG:876) Profits Appear To Have Quality Issues

Oct 05
Kaisa Health Group Holdings' (HKG:876) Profits Appear To Have Quality Issues

We Think Kaisa Health Group Holdings (HKG:876) Can Afford To Drive Business Growth

Jul 30
We Think Kaisa Health Group Holdings (HKG:876) Can Afford To Drive Business Growth

Would Shareholders Who Purchased Kaisa Health Group Holdings' (HKG:876) Stock Five Years Be Happy With The Share price Today?

Jan 26
Would Shareholders Who Purchased Kaisa Health Group Holdings' (HKG:876) Stock Five Years Be Happy With The Share price Today?

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Kaisa Health Group Holdings n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

SEHK:876 - Estimations futures des analystes et données financières antérieures (HKD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
6/30/2024182-57-64-61N/A
3/31/2024184-25-55-48N/A
12/31/20231867-47-36N/A
9/30/202318811-38-22N/A
6/30/202319014-29-8N/A
3/31/2023191-55-51-33N/A
12/31/2022191-123-73-59N/A
9/30/2022196-139-167-143N/A
6/30/2022200-155-262-227N/A
3/31/2022205-76-212-175N/A
12/31/20212102-162-123N/A
9/30/202121015-65-40N/A
6/30/2021211273242N/A
3/31/2021197-6-156N/A
12/31/2020184-40-61-31N/A
9/30/2020196-203134N/A
6/30/2020209-36663100N/A
3/31/2020230-3601946N/A
12/31/2019252-355-24-8N/A
9/30/2019243-186-81-63N/A
6/30/2019234-18-139-118N/A
3/31/2019238-20-87-62N/A
12/31/2018242-22-34-7N/A
9/30/2018247-13N/AN/AN/A
6/30/2018252-4-30-12N/A
3/31/20182391N/A-3N/A
12/31/20172276N/A6N/A
6/30/20171952N/A22N/A
3/31/20171920N/A16N/A
12/31/2016188-2N/A11N/A
6/30/20162719N/A3N/A
3/31/2016635N/A30N/A
12/31/2015100-10N/A57N/A
9/30/2015376-77N/A-14N/A
6/30/2015356-123N/A-85N/A
3/31/2015360-107N/A-106N/A
12/31/2014363-90N/A-127N/A
9/30/2014357-56N/A-53N/A
6/30/2014351-23N/A21N/A
3/31/2014334-33N/A21N/A
12/31/2013316-44N/A21N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if 876's forecast earnings growth is above the savings rate (2.3%).

Bénéfices vs marché: Insufficient data to determine if 876's earnings are forecast to grow faster than the Hong Kong market

Croissance élevée des bénéfices: Insufficient data to determine if 876's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: Insufficient data to determine if 876's revenue is forecast to grow faster than the Hong Kong market.

Croissance élevée des revenus: Insufficient data to determine if 876's revenue is forecast to grow faster than 20% per year.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if 876's Return on Equity is forecast to be high in 3 years time


Découvrir les entreprises en croissance